By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Norwegian enzymes firm ArcticZymes and Swedish gene expression profiling company Tataa Biocenter today announced a mutual sales and distribution deal covering Europe.

The terms of the agreement calls for Tataa to sell ArcticZymes' heat-labile enzymes for use in contamination control through its sales channels. Tataa will also integrate ArcticZymes' products into its range of courses.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.